Loading clinical trials...

EPIPAGE2 Cohort Study Follow up at Five and a Half Years | Clinical Trials | Clareo Health

COMPLETEDNCT03078439

EPIPAGE2 Cohort Study Follow up at Five and a Half Years

Epipage 2 (epidemiologic study on small-for-gestational-age children) is a nationwide study implemented to improve our knowledge of the outcome of preterm children in France. This study was launched o...

Lead sponsor: Institut National de la Santé Et de la Recherche Médicale, France•98 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Enrolling By InvitationNA

High-Dose Intravenous Lipid for Very Preterm or Very Low Birth Weight Infants Effects on Growth

NCT06909929 · Very Preterm Birth

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 15, 2026Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment3,404

Start dateSep 2016

Last updatedApr 15, 2026

Condition

Very Preterm Birth

Locations shown

Centre Hopsitalier d'Agen

Agen

CAMSP Albi

Albi

CHU Amiens

Amiens

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 15, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions